Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Muthiah Vaduganathan Added: 2 years ago
HFA 24 - We are joined by Dr Muthiah Vaduganathan (Brigham and Women’s Hospital, US) to discuss the design and baseline characteristics of the FINE-HEART(Bayer) integrated pooled analysis of finerenone, an on-steroidal mineralocorticoid receptor (MRA) antagonist, in over 19000 patients with heart failure and CKD.FINE-HEART includes patients with type 2 diabetes, chronic kidney disease and/or… View more
Research Area(s) / Expertise:

Diabetes

Job title: Angiologist
Dr Martin Andrassy is an angiologist working in Germany with a clinical focus on vascular medicine. He practices at the Fuerst-Stirum Hospital in Bruchsal, where he is part of the Department of Cardiology, Vascular Medicine and Diabetology. His work centres on the diagnosis and management of vascular diseases within a multidisciplinary cardiovascular and metabolic care setting.Academic HistoryDr… View more
Author(s): Carolyn Lam , Jeffrey Weitz Added: 9 months ago
Hear from Prof Carolyn Lam and Prof Jeffrey Weitz as they share key take-home messages from ESC 2025.Filmed onsite, this peer-to-peer discussion distils the latest updates in thrombosis management for acute coronary syndrome (ACS), secondary stroke prevention (SSP) and atrial fibrillation (AF).Register for the upcoming Q&A webinar, taking place on 6 October (14:00 EDT / 20:00 CEST), to put your… View more
Job title: Neurointerventional and Interventional Radiologist
Dr Roger Barranco Pons is an Interventional and Neurointerventional radiologist with over 14 years of experience in the management of vascular diseases. He currently serves as a Neurointerventional and Interventional Radiologist at the NeuroSpinal Hospital in Dubai, UAE. Dr Pons' clinical interests include neurovascular disease, vascular disease, oncology and musculoskeletal interventions. … View more
Research Area(s) / Expertise: Job title: Professor of Medicine in the Division of Nephrology
Dr Navdeep Tangri is a Professor of Medicine in the Division of Nephrology at University of Manitoba, Winnipeg, CA.Dr Tangri's research programme is focused on the clinical management of patients with advanced chronic kidney disease. He developed the kidney failure risk equation (KFRE) to predict the need for dialysis in patients with chronic kidney disease. View more
Job title: Consultant Interventional Cardiologist
Dr Kalpa De Silva has been a consultant interventional cardiologist at Guy's and St Thomas'NHS Foundation Trust since 2020. Previously he was a consultant interventional cardiologist at the Bristol Heart Institute, University Hospitals Bristol NHS Foundation Trust. He specialises in the management of coronary artery disease, looking after patients with chest pain, angina and those who have… View more
Research Area(s) / Expertise: Job title: Pharmacist
Mr Chan Hong is an ambulatory Pharmacist in National Heart Centre Singapore (NHCS). He is currently involved in managing ambulatory clinics in areas of anticoagulation, smoking cessation and heart failure management. He is a keen advocate for patient empowerment and education to improve disease prevention and public health. He is currently involved in the formulation and review of Patient… View more
Research Area(s) / Expertise:

Venous Disease - General

Job title: Associate Professor of Radiology, Surgery and Medicine; Director, Deep Venous Interventions
Dr Kush R Desai, MD, FSIR is an Interventional Radiologist and Associate Professor of Radiology, Surgery, and Medicine at Northwestern University. His primary research and clinical interests are in venous thromboembolic disease, deep venous thrombectomy/thrombolysis, reconstruction of chronic venous occlusions, IVC filter management/complex IVC filter retrieval, and interventional pulmonary… View more
Author(s): Muthiah Vaduganathan Added: 2 years ago
HFA 24 - We are joined by Dr Muthiah Vaduganathan (Brigham and Women’s Hospital, US) to discuss the findings from a study of four large-scale placebo controlled-trials investigating the timing of cardio-kidney protection with SGLT2 inhibitors.4 trials that sampled distinct patient populations were enrolled in the trial - the CANVAS program, the CREDENCE trial, DAPA-HF and DELIVER. Across each… View more